126 related articles for article (PubMed ID: 12659094)
1. Tetrahydrobiopterin-responsive hyperphenylalaninaemia due to homozygous mutations in the phenylalanine hydroxylase gene.
Blau N; Bernegger C; Trefz FK
Eur J Pediatr; 2003 Mar; 162(3):196. PubMed ID: 12659094
[No Abstract] [Full Text] [Related]
2. Tetrahydrobiopterin for patients with phenylketonuria.
Pey AL; Martinez A
Lancet; 2007 Aug; 370(9586):462-3. PubMed ID: 17693159
[No Abstract] [Full Text] [Related]
3. The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.
Blau N; Erlandsen H
Mol Genet Metab; 2004 Jun; 82(2):101-11. PubMed ID: 15171997
[TBL] [Abstract][Full Text] [Related]
4. Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.
Kure S; Hou DC; Ohura T; Iwamoto H; Suzuki S; Sugiyama N; Sakamoto O; Fujii K; Matsubara Y; Narisawa K
J Pediatr; 1999 Sep; 135(3):375-8. PubMed ID: 10484807
[TBL] [Abstract][Full Text] [Related]
5. Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency: possible regulation of gene expression in a patient with the homozygous L48S mutation.
Blau N; Trefz FK
Mol Genet Metab; 2002 Feb; 75(2):186-7. PubMed ID: 11855940
[No Abstract] [Full Text] [Related]
6. Functional Characterization of Novel Phenylalanine Hydroxylase p.Gln226Lys Mutation Revealed Its Non-responsiveness to Tetrahydrobiopterin Treatment in Hepatoma Cellular Model.
Klaassen K; Djordjevic M; Skakic A; Desviat LR; Pavlovic S; Perez B; Stojiljkovic M
Biochem Genet; 2018 Oct; 56(5):533-541. PubMed ID: 29654578
[TBL] [Abstract][Full Text] [Related]
7. Mental illness in mild PKU responds to biopterin.
Koch R; Guttler F; Blau N
Mol Genet Metab; 2002 Mar; 75(3):284-6. PubMed ID: 11914042
[TBL] [Abstract][Full Text] [Related]
8. Tetrahydrobiopterin, its mode of action on phenylalanine hydroxylase, and importance of genotypes for pharmacological therapy of phenylketonuria.
Heintz C; Cotton RG; Blau N
Hum Mutat; 2013 Jul; 34(7):927-36. PubMed ID: 23559577
[TBL] [Abstract][Full Text] [Related]
9. Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria.
Muntau AC; Röschinger W; Habich M; Demmelmair H; Hoffmann B; Sommerhoff CP; Roscher AA
N Engl J Med; 2002 Dec; 347(26):2122-32. PubMed ID: 12501224
[TBL] [Abstract][Full Text] [Related]
10. [Genotyping and treatment modification in patients with phenylketonuria: an introduction to pharmacogenomics].
Bik-Multanowski M; Pietrzyk JJ
Przegl Lek; 2009; 66(1-2):1-3. PubMed ID: 19485247
[TBL] [Abstract][Full Text] [Related]
11. A limited spectrum of phenylalanine hydroxylase mutations is observed in phenylketonuria patients in western Poland and implications for treatment with 6R tetrahydrobiopterin.
Dobrowolski SF; Borski K; Ellingson CC; Koch R; Levy HL; Naylor EW
J Hum Genet; 2009 Jun; 54(6):335-9. PubMed ID: 19444284
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the regulatory domain of phenylalanine hydroxylase and response to tetrahydrobiopterin.
Wang L; Surendran S; Michals-Matalon K; Bhatia G; Tanskley S; Koch R; Grady J; Tyring SK; Stevens RC; Guttler F; Matalon R
Genet Test; 2007; 11(2):174-8. PubMed ID: 17627389
[TBL] [Abstract][Full Text] [Related]
13. Tetrahydrobiopterin responsiveness: results of the BH4 loading test in 31 Spanish PKU patients and correlation with their genotype.
Desviat LR; Pérez B; Bèlanger-Quintana A; Castro M; Aguado C; Sánchez A; García MJ; Martínez-Pardo M; Ugarte M
Mol Genet Metab; 2004; 83(1-2):157-62. PubMed ID: 15464430
[TBL] [Abstract][Full Text] [Related]
14. New insights into tetrahydrobiopterin pharmacodynamics from Pah enu1/2, a mouse model for compound heterozygous tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.
Lagler FB; Gersting SW; Zsifkovits C; Steinbacher A; Eichinger A; Danecka MK; Staudigl M; Fingerhut R; Glossmann H; Muntau AC
Biochem Pharmacol; 2010 Nov; 80(10):1563-71. PubMed ID: 20705059
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetics of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.
Zurflüh MR; Zschocke J; Lindner M; Feillet F; Chery C; Burlina A; Stevens RC; Thöny B; Blau N
Hum Mutat; 2008 Jan; 29(1):167-75. PubMed ID: 17935162
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment and diagnosis of tetrahydrobiopterin-responsive hyperphenylalaninemia with a mutant phenylalanine hydroxylase gene.
Shintaku H; Kure S; Ohura T; Okano Y; Ohwada M; Sugiyama N; Sakura N; Yoshida I; Yoshino M; Matsubara Y; Suzuki K; Aoki K; Kitagawa T
Pediatr Res; 2004 Mar; 55(3):425-30. PubMed ID: 14681498
[TBL] [Abstract][Full Text] [Related]
17. Tetrahydrobiopterin responsiveness in phenylketonuria. Two new cases and a review of molecular genetic findings.
Lässker U; Zschocke J; Blau N; Santer R
J Inherit Metab Dis; 2002 Feb; 25(1):65-70. PubMed ID: 11999982
[TBL] [Abstract][Full Text] [Related]
18. Effects and clinical significance of tetrahydrobiopterin supplementation in phenylalanine hydroxylase-deficient hyperphenylalaninaemia.
Gramer G; Burgard P; Garbade SF; Lindner M
J Inherit Metab Dis; 2007 Aug; 30(4):556-62. PubMed ID: 17680344
[TBL] [Abstract][Full Text] [Related]
19. Structural studies on phenylalanine hydroxylase and implications toward understanding and treating phenylketonuria.
Erlandsen H; Patch MG; Gamez A; Straub M; Stevens RC
Pediatrics; 2003 Dec; 112(6 Pt 2):1557-65. PubMed ID: 14654665
[TBL] [Abstract][Full Text] [Related]
20. Tetrahydrobiopterin responsiveness in phenylketonuria differs between patients with the same genotype.
Lindner M; Haas D; Mayatepek E; Zschocke J; Burgard P
Mol Genet Metab; 2001 May; 73(1):104-6. PubMed ID: 11350190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
